A Study of AZD0120 in Autoimmune Diseases

Trial Identifier: D8318C00001
Sponsor: AstraZeneca
Start Date: January 2026
Primary Completion Date: February 2028
Study Completion Date: February 2028
Condition: Rheumatoid Arthritis

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
AU Darlinghurst, AU, 2010
AU Waratah, AU, 2298
DE Hamburg, DE, 20246
DE Mainz am Rhein, DE, 55131
DE Würzburg, DE, 97080
ES Barcelona, ES, 8035
ES Madrid, ES, 28041
ES Madrid, ES, 28046
GB Edinburgh, GB, EH4 2XU
GB London, GB, SE5 9RS
US, AZ Tucson, AZ, US, 85719
US, CA Stanford, CA, US, 94305-5847
US, IL Chicago, IL, US, 60637
US, MI Ann Arbor, MI, US, 48109
US, MO Saint Louis, MO, US, 63110
US, NC Chapel Hill, NC, US, 27514
US, NY New York, NY, US, 10032
US, WA Seattle, WA, US, 98104